TL;DR
This study reveals that the bacterial RNA chaperone Hfq plays a critical role in Pseudomonas aeruginosa's antibiotic resistance by influencing energy metabolism and cell wall composition. By manipulating the regulatory RNA CrcZ, researchers demonstrate a promising strategy to re-sensitize these notoriously drug-resistant bacteria to existing antibiotics.
What Problem Does This Paper Address?
Pseudomonas aeruginosa is a major cause of hospital-acquired infections, notorious for its formidable intrinsic resistance to a wide range of antibiotics, which is further exacerbated by the increasing prevalence of multi-drug resistant strains. This poses a significant challenge for clinical treatment. Understanding the molecular mechanisms behind this resistance is crucial for developing novel therapeutic strategies, including ways to re-sensitize bacteria to antibiotics already in use. Previous work by the authors identified Hfq, a key RNA-binding protein, as a translational repressor involved in carbon catabolite repression (CCR) in P. aeruginosa, working in concert with the Crc protein. This repression is counteracted by the regulatory RNA CrcZ, which acts as a decoy for Hfq. This paper investigates the broader role of Hfq in antibiotic susceptibility and explores how manipulating the Hfq-CrcZ interaction could be a viable strategy to combat antibiotic resistance.
Methods
The researchers employed a multi-pronged approach:
- Antibiotic Susceptibility Testing: Minimal Inhibitory Concentration (MIC) assays were performed using various classes of antibiotics on wild-type and hfq deletion mutant strains of P. aeruginosa (PAO1 and PA14). This was done under different inoculum sizes and growth conditions (SCFM and LB media) to assess the impact of Hfq.
- Transcriptome Analysis (RNAseq): RNA sequencing was used to compare the gene expression profiles of wild-type PA14 and the PA14Δhfq mutant. This aimed to identify genes and pathways regulated by Hfq that are relevant to antibiotic resistance.
- Membrane Potential Measurement: Flow cytometry with the dye DiOC2(3) was used to assess the proton motive force (PMF) and membrane potential in wild-type and mutant strains, as PMF is known to influence antibiotic uptake.
- c-di-GMP Assay: A transcriptional reporter system (pCdrA::gfp(ASV)C) sensitive to cyclic-di-GMP (c-di-GMP) levels was used to quantify intracellular c-di-GMP in wild-type and mutant strains.
- Biofilm Assay: Standard crystal violet staining was used to quantify biofilm formation in wild-type and mutant strains.
- Northern Blot Analysis: This technique was used to confirm the expression levels of the regulatory RNA CrcZ in strains engineered to overproduce it.
- Plasmid-Based Manipulation: Strains were engineered to constitutively express CrcZ using a plasmid (pMMBcrcZ) to investigate the effect of increased CrcZ levels on antibiotic susceptibility.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Hfq is a broad regulator of antibiotic susceptibility: Deleting the hfq gene significantly increased the susceptibility of P. aeruginosa to multiple classes of antibiotics, including beta-lactams, aminoglycosides, fluoroquinolones, and tetracyclines. This suggests Hfq's role extends beyond its previously known function in CCR.
- Hfq influences core cellular processes linked to resistance: Transcriptome analysis revealed that Hfq regulates genes involved in crucial pathways for antibiotic resistance, including import/efflux systems, energy metabolism, and cell wall/LPS composition.
- Hfq impacts energy metabolism and membrane potential: The absence of Hfq led to a reduced membrane potential, which is counterintuitive given that some efflux pumps require PMF. This suggests a complex interplay where Hfq's absence might impair energy generation pathways that indirectly affect antibiotic resistance mechanisms.
- Hfq is a key regulator of c-di-GMP levels: hfq deletion mutants exhibited significantly lower intracellular c-di-GMP levels, which are known to be important for biofilm formation and can influence antibiotic tolerance.
- CrcZ is a potent modulator of antibiotic susceptibility: Overexpressing the regulatory RNA CrcZ, which acts as a decoy for Hfq, mimicked the increased antibiotic susceptibility observed in hfq deletion mutants. This highlights the potential of targeting the Hfq-CrcZ interaction.
- Metabolic rewiring can enhance antibiotic efficacy: Inducing CrcZ synthesis by growing bacteria on non-preferred carbon sources (like oxaloacetate) or by direct induction led to increased susceptibility to antibiotics like gentamicin and cefepime. This demonstrates a direct link between metabolic state and antibiotic response.
Key Results
- hfq deletion strains showed a 4-fold or greater increase in susceptibility to tested antibiotics like cefepime, fosfomycin, gentamicin, and tetracycline compared to wild-type strains, regardless of inoculum size.
- RNAseq analysis identified 301 upregulated and 213 downregulated transcripts in the PA14Δhfq mutant compared to PA14, with significant enrichment in categories related to carbon/amino acid metabolism, transporters/efflux pumps, and energy metabolism.
- Flow cytometry indicated a ~50% reduction in membrane potential in hfq deletion strains compared to wild-type.
- c-di-GMP reporter assays showed a ~60-70% reduction in GFP activity in hfq deletion mutants, correlating with reduced biofilm formation.
- Overproduction of CrcZ in PA14 and PAO1 strains led to a significant increase in susceptibility to gentamicin, with MICs dropping from 16 mg/L to 6 mg/L (PA14) and 24 mg/L to 12 mg/L (PAO1).
Limitations and Future Work
- Reconciling Transcriptome and Phenotype: The study notes a discrepancy between the RNAseq data suggesting increased PMF due to cox operon upregulation and the experimental finding of reduced PMF in hfq mutants. The authors suggest that Hfq's regulatory roles at the translational and post-translational levels, which are not captured by transcriptome analysis, might explain this.
- Signal for CrcZ Synthesis: The specific signal sensed by the CbrA/B two-component system that controls CrcZ synthesis remains unknown, but its elucidation could allow for targeted induction of CrcZ in clinical settings.
- Hfq-Crc Complex Regulation: While the Hfq-Crc complex is implicated in translational repression, the precise mechanisms by which Hfq regulates specific antibiotic resistance genes (e.g., oprD, glpT) at the translational or post-transcriptional level require further detailed investigation.
- Biofilm Susceptibility: The paper mentions that hfq deletion leads to less efficient biofilm formation and suggests testing whether hfq inactivation could increase biofilm susceptibility to antibiotics.
- Hfq as a Drug Target: The authors propose that the Hfq-Crc complex is a promising drug target for developing strategies to enhance antibiotic efficacy.
This research opens exciting avenues for developing novel strategies to combat antibiotic resistance by targeting metabolic regulation and RNA-based control mechanisms in P. aeruginosa.
Summary updated